Detalles de la búsqueda
1.
Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer.
Jpn J Clin Oncol
; 54(3): 305-311, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38213068
2.
Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.
Jpn J Clin Oncol
; 51(7): 1114-1122, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33881137
3.
Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab.
Int J Clin Oncol
; 23(4): 634-640, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29442281
4.
Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.
Jpn J Clin Oncol
; 51(7): 1183, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34100088
5.
Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR Mutations.
JTO Clin Res Rep
; 5(2): 100636, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361742
6.
Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodies.
Respir Investig
; 61(1): 74-81, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36460585
7.
Distinct metastatic spread and progression patterns in patients treated with crizotinib for ROS1- and ALK-rearranged non-small cell lung cancer: a single-center retrospective study.
Transl Lung Cancer Res
; 12(7): 1436-1444, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37577313
8.
Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancer.
Lung Cancer
; 178: 247-253, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913912
9.
Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non-small cell lung cancer patients.
Cancer Med
; 12(11): 12388-12401, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062059
10.
End-of-life impact of concurrent diabetes mellitus and adrenal insufficiency as immune-related adverse events in an advanced non-small cell lung cancer patient.
Thorac Cancer
; 13(21): 3073-3075, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195556
11.
Lorlatinib Versus Pemetrexed-Based Chemotherapy in Patients With ALK-rearranged NSCLC Previously Treated With Alectinib.
JTO Clin Res Rep
; 3(5): 100311, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35498380
12.
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.
Cancer Cell
; 40(2): 201-218.e9, 2022 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090594
13.
The Impact of Core Tissues on Successful Next-Generation Sequencing Analysis of Specimens Obtained through Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.
Cancers (Basel)
; 13(23)2021 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34884991
14.
Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS ≥ 50%) NSCLC.
Clin Lung Cancer
; 22(2): 127-133.e3, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33183972
15.
Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors.
JCO Precis Oncol
; 52021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34036223
16.
Comparative study of programmed cell death ligand-1 immunohistochemistry assays using 22C3 and 28-8 antibodies for non-small cell lung cancer: Analysis of 420 surgical specimens from Japanese patients.
Lung Cancer
; 125: 230-237, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429026
17.
Phase I/II study of erlotinib, carboplatin, pemetrexed, and bevacizumab in chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer harboring epidermal growth factor receptor mutation.
Genes Cancer
; 8(5-6): 559-565, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28740574
18.
Retrospective analysis of single-agent nab-paclitaxel in patients with platinum-resistant non-small cell lung cancer.
Mol Clin Oncol
; 7(5): 803-807, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29181169
19.
Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer.
Case Rep Oncol
; 10(2): 683-688, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28878650
20.
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case report.
Clin Case Rep
; 5(12): 2047-2050, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29225854
Resultados
1 -
20
de 20
1
Próxima >
>>